Navigation Links
Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
Date:9/17/2007

nts with cystic fibrosis and other serious lung diseases."

"In addition, we are eager to use his expertise in the development of our proprietary class of efflux pump inhibitors, which are now approaching the development stage. Lastly, we believe Jeff can be an integral part of evaluating and subsequently prosecuting attractive clinical-stage in-licensing opportunities. With the addition of Jeff we have now assembled a clinical team that is highly experienced in all aspects of trial design and management and is capable of advancing a drug candidate through late-stage development," added Burgess.

"I am pleased to be joining Mpex at this exciting time," said Dr. Loutit. "Based on preclinical and early clinical data, MP-376, the company's lead product, has the potential to be a best-in-class aerosol anti-infective for management of chronic lung infections in patients suffering from CF and other serious lung conditions. In addition, Mpex scientists are widely acknowledged as leaders in the area of efflux pump biology, a primary source of antibiotic resistance in gram negative organisms. The impressive progress this group has made over the last year in developing efflux pump inhibitors may lead to a clinical candidate in the near-term for one of the most intractable problems in infectious disease drug development. I am eager to work with the Mpex team to establish the Company as a leader in the development of novel approaches to overcoming gram-negative antibiotic resistance."

About Mpex Pharmaceuticals:

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop critical new therapies to combat the growing issue of antibiotic resistance. The company's initial focus is on the treatment of gram-negative bacterial pathogens such as Pseudomonas aeruginosa, for which limited effective treatment options exist. Mpex's lead product candidate, MP-376, is currently in clinical trials and is being developed for the treatmen
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Wisconsin IT association names Gee president, CEO
4. Quintessence Biosciences names new president
5. CDW names VP to handle Berbee merger
6. NimbleGen names CFO with capital-raising past
7. Cisco names Berbee a top partner of 2005
8. Cisco names Inacom most innovative partner
9. UW-Madison medical school names new dean
10. GE Healthcare names new CEO
11. Bruker AXS names new leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 2015 , ... A study by a multidisciplinary research team, ... adapt through genetic modifications to fight back against the effects of medication designed ... insights may provide clues to new ways to treat notoriously difficult-to-cure fungal infections ...
(Date:7/6/2015)... DUBLIN , June 29, 2015 ... ) has announced the addition of the ... offering. Biotechnology for the Non-Biotechnologist, ideal ... basic theory, principles, techniques and potential of biotechnology. ... to understand the basic theory, principles, techniques, and ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... in applications such as animal waste reduction, bioremediation, wastewater treatment, aquaculture and ... settings, announced today that it will be showcasing, ManureMagic™, its industry-leading product ...
(Date:7/3/2015)... 3, 2015 Forskere ... Innovation in Science", som finner sted i ... på nett, på  http://www.openinnovationinscience.at , og søknadsperioden ... De to største utfordringene innen helsevitenskapen ... nye forskningsspørsmål og kompleksiteten av nåværende forskningsresultater, ...
Breaking Biology Technology:Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4DryLet to Highlight Benefits of Patented ManureMagic™ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3
... Webcast Presentation Scheduled for Wednesday, January 14, 2009 at ... Colo. and SAN CARLOS, Calif., Jan. 8 ARCA ... heart failure and other cardiovascular diseases, and Nuvelo, Inc. ... Brewer, ARCA,s president and chief executive officer, will present ...
... Concentric Medical, Inc., the global leader in devices ... that it has completed a $15 million round of ... capital firm New Enterprise Associates, Inc. (NEA) and includes ... Concentric over the last several months made the opportunity ...
... Remote Patient Monitoring Projected to Exceed $8 Billion ... Inc., developer of LifeShirt(R), a continuous, integrated and ... that president and chief executive officer Howard Baker ... January 14, 2009 at the Marines Memorial Club ...
Cached Biology Technology:ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 2ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 3ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 4ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 5Concentric Medical Closes on $15 Million Financing 2VivoMetrics to Present at the 2009 Biotech Showcase 2VivoMetrics to Present at the 2009 Biotech Showcase 3
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... including all touch fingerprint sensors in the company,s portfolio from ... . Deliveries are planned to mainly take place during the ... manufacturers in Asia . Jörgen ... another evidence of    the   growing interest from smartphone ...
(Date:6/15/2015)... -- According to a new market research ... and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... The Natural Language Processing Market is expected to grow ... the forecast period 2015-2020. Browse 65 ... spread   through 155 P ages and in-depth ...
(Date:6/15/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... announces that its leading payment security technology, the Wocket® smart ... NYC June 18th. Digital Experience! @ NYC is ... to over 300 of the top media covering the sector. ... New York City from 6:00 to ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... to evolution; it allows genetic material from parents to ... how did sex itself evolve" Researchers at the Department ... of California at Berkeley have found clues to one ... the nematode Caenorhabditis elegans. , Abby Dernburg, of ...
... Chocolate Chip Cookies TM lower cholesterol and improve ... according to a published study in The Journal of ... a combination of psyllium and plant sterols, are a ... cholesterol. , The American Heart Association estimates at ...
... a screen and a bucket, scientists studying a tiny primitive ... Tampa Bay now say they have found the "missing link" ... of the modern-day human immune system. , The inch-long spineless ... that is similar to but much hardier than the version ...
Cached Biology News:New clues to how sex evolves 2New clues to how sex evolves 3New clues to how sex evolves 4New study finds chocolate chip cookies lower cholesterol 2Tiny Tampa Bay fish key to evolution of immune system 2Tiny Tampa Bay fish key to evolution of immune system 3
... a base medium for preparation of minimal and ... but does not contain amino acids. Both bulk ... pouch contains reagents to prepare 500 ml of ... of 10X YNB for S. cerevisiae media. Store ...
... Progesterone Receptor (PR) Competitor Assay Kits ... novel progesterone receptor binding compounds using ... utilizes a fusion of glutathione transferase ... human progesterone receptor [PR-LBD(GST)] and a ...
... Protein G bind specifically to Fc regions ... Protein G conjugates are commonly used as ... immunoglobulin subtypes from serum, hybridoma ascites fluids, ... These reagents are also commonly used to ...
... the first instrument engineered to match the ... by thousands of research centers worldwide. It ... which are ideally suited for high-speed temperature ... extremely high surface-area-to-volume ratio. ,By combining glass ...
Biology Products: